A prospective observational cohort study of HIV-positive individuals in Europe, Israel and Argentina
EuroSIDA is a prospective observational cohort study that was initiated in 1994 to follow the long-term clinical prognosis for the general population of HIV-infected individuals in Europe and to assess the impact of antiretroviral drug treatment on their long-term prognosis.
To date almost 23000 individuals have been followed in 100 collaborating clinics across 35 countries covering all European regions, Israel and Argentina. EuroSIDA aims to study the long-term virological, immunological and clinical outcomes and to monitor temporal changes and regional differences across Europe. EuroSIDA has investigated co-infection with Hepatitis C virus and clinical events including liver, renal and cardiovascular disease and non-AIDS defining cancers.
EuroSIDA was one of the cohorts to found The International Cohort Consortium of Infectious Disease (RESPOND) cohort consortium on infectious diseases in 2017.